A systematic review of COVID-19 and the presentation of avoidant/restrictive food intake disorder and avoidant/restrictive food intake disorder-like symptoms.

Avoidant/restrictive food intake disorder COVID-19 clinical presentation eating disorders prevalence

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
04 Mar 2024
Historique:
medline: 4 3 2024
pubmed: 4 3 2024
entrez: 4 3 2024
Statut: epublish

Résumé

The adverse effects of COVID-19 and the associated restrictions on eating disorder populations have been discussed in recent literature. However, little is known about the presentation of cases with avoidant/restrictive food intake disorder (ARFID) during this period. To explore the extent of the literature on the presentation of ARFID, and ARFID-like cases, during the COVID-19 pandemic. Cochrane Library, CINAHL (EBSCO), PsycINFO (EBSCO), EMBASE (Ovid) and Medline (Ovid) were searched for publications between March 2020 and May 2023. Google Scholar and reference lists were hand searched. At least two reviewers independently screened each paper. Narrative synthesis was used. Seven papers were included: four case reports and three cohort studies (total ARFID sample of 46). Included papers were assessed as having high ( Publications specifically pertaining to ARFID presentations during the COVID-19 pandemic have been few. Papers found have been of small sample sizes and lack subanalyses for ARFID within broader eating disorder samples. Continued surveillance is needed to evaluate any COVID-19-specific effects on the development, identification, treatment and outcomes of ARFID.

Sections du résumé

BACKGROUND BACKGROUND
The adverse effects of COVID-19 and the associated restrictions on eating disorder populations have been discussed in recent literature. However, little is known about the presentation of cases with avoidant/restrictive food intake disorder (ARFID) during this period.
AIMS OBJECTIVE
To explore the extent of the literature on the presentation of ARFID, and ARFID-like cases, during the COVID-19 pandemic.
METHOD METHODS
Cochrane Library, CINAHL (EBSCO), PsycINFO (EBSCO), EMBASE (Ovid) and Medline (Ovid) were searched for publications between March 2020 and May 2023. Google Scholar and reference lists were hand searched. At least two reviewers independently screened each paper. Narrative synthesis was used.
RESULTS RESULTS
Seven papers were included: four case reports and three cohort studies (total ARFID sample of 46). Included papers were assessed as having high (
CONCLUSIONS CONCLUSIONS
Publications specifically pertaining to ARFID presentations during the COVID-19 pandemic have been few. Papers found have been of small sample sizes and lack subanalyses for ARFID within broader eating disorder samples. Continued surveillance is needed to evaluate any COVID-19-specific effects on the development, identification, treatment and outcomes of ARFID.

Identifiants

pubmed: 38433590
doi: 10.1192/bjo.2023.655
pii: S2056472423006555
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e56

Auteurs

Kristen Maunder (K)

Department of Child and Adolescent Psychiatry, University College Dublin, Ireland; Department of Liaison Child and Adolescent Psychiatry, Tallaght University Hospital, Ireland; and Department of Child and Adolescent Psychiatry, Linn Dara Child and Adolescent Mental Health Services, Dublin, Ireland.

Oscar Markey (O)

Department of Psychology, Universiteit Leiden, The Netherlands; Department of Psychology, Trinity College Dublin, Ireland; and Department of Child and Adolescent Psychiatry, Lucena St John of God's Child and Adolescent Mental Health Services, Dublin, Ireland.

Rachel Batchelor (R)

Department of Psychology, Oxford Institute of Clinical Psychology Training and Research, UK; and Department of Psychology, Oxford Health NHS Foundation Trust, UK.

Fiona McNicholas (F)

Department of Child and Adolescent Psychiatry, University College Dublin, Ireland; Department of Child and Adolescent Psychiatry, Lucena St John of God's Child and Adolescent Mental Health Services, Dublin, Ireland; and Department of Liaison Child and Adolescent Psychiatry, Children's Health Ireland at Crumlin, Ireland.

Classifications MeSH